drugset / Trial / NCT04113941
Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is for patients who have idiopathic overactive bladder symptoms. This study will evaluate efficacy and safety of Neuronox® against placebo.
Timeline
- Start
- 2019-08-23
- Primary completion
- 2020-04-15
- Completion
- 2021-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neuronox | Protein / enzyme biologic | 100 iu | Other |